Portfolio company
Insitro
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This deep-tech company uses machine learning and genomic data to develop therapeutic drugs for patients with various human diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Leash Bio
This deep-tech company generates large-scale biochemical datasets and machine learning models to assist biopharmaceutical partners and internal teams in designing new medicinal drugs.
Rewrite Therapeutics
This deep-tech company develops DNA writing and genome editing tools for biotechnology firms to treat genetic diseases.
Cartography Biosciences
This deep-tech company develops precision cancer therapeutics and drug targets for healthcare providers using computational biology and machine learning platforms.
DeepMirror
This company develops an artificial intelligence platform for medicinal chemists at biotechnology and pharmaceutical firms to design and optimise drug molecules.
Axiom Therapeutics
This deep-tech company develops covalent medicines for pharmaceutical organisations using an artificial intelligence drug discovery platform.
A-Alpha Bio
This deep-tech company provides protein interaction data and predictive models to pharmaceutical firms for the discovery and engineering of new medicines.
Seismic Therapeutic
The company develops immunology therapies for autoimmune and allergic diseases using machine learning for biologics discovery in the deep-tech sector.
Enveda Bioscience
This company develops small molecule medicines for patients with inflammatory and metabolic diseases by using machine learning to map natural plant chemistry.
